FH

Francis Ho

Partner at Walden Catalyst Ventures

Palo Alto, California

Overview 

Francis Ho is a Deeptech VC at Walden Catalyst Ventures in Palo Alto, California, specializing in semiconductors, deep tech, digital health, and other innovative sectors. He has successfully invested in companies like Peptone, Genome Medical, and IonQ, contributing to their growth and development through strategic partnerships and business insights.

Work Experience 

  • Partner

    2021 - Current

Walden Catalyst provides early-stage investments and operational expertise in data, deep tech, AI, cloud, and digital biology.

  • Board Observer

    2024

  • Board Member

    2022

  • Board Observer

    2022

  • Senior Vice President and Co-Head

    2012 - 2021

Samsung Catalyst fosters innovation through guidance, expertise, and connections to transform ideas into products at scale.

  • Investor

    2020 - 2021

  • Board Observer

    2020 - 2021

Genome Medical is a telegenomics technology and services company allowing access to genomic-based medicine.

Raised $195,744,304.00 from Perceptive Advisors, Amgen Ventures, Alumni Ventures, Illumina Ventures, Casdin Capital, Revelation Partners, Echo Health Ventures, Avestria Ventures, HealthInvest Equity Partners and Kaiser Permanente Ventures.

  • Board Member

    2019 - 2021

Avicena Tech manufactures ultra-dense, ultra-low power petabit per second optical chip interconnects.

Raised $32,955,606.00 from Clear Ventures, Micron Ventures, Cerberus Capital Management and Samsung Catalyst Fund.

  • Board Observer

    2019 - 2021

  • Investor

    2018 - 2021

Samsara Biocapital provides investment advisory services to help entrepreneurs turn their own ideas and visions into successful companies.

Articles About Francis

Relevant Websites